ROSE-AHF and Lessons Learned View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-06-26

AUTHORS

Amit K. Jain, Horng H. Chen

ABSTRACT

Nesiritide and dopamine have been recognized for some time as potential renal adjunct therapies in the management of patients with acute heart failure (AHF). Several studies have yielded conflicting evidence of the efficacy of both medications in enhancing the renal function of patients with AHF. The Renal Optimization Strategies Evaluation (ROSE) study was a multicenter double-blind placebo controlled trial designed to assess the potential renoprotective effects of low-dose nesiritide and dopamine in AHF patients with renal dysfunction. This article will focus on previous research, summary of results, and lessons learned from the ROSE-AHF trial as well as future directions for clinical research and applications. More... »

PAGES

260-265

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11897-014-0208-6

DOI

http://dx.doi.org/10.1007/s11897-014-0208-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1043129398

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24966060


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Kidney Injury", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose-Response Relationship, Drug", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Natriuretic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Natriuretic Peptide, Brain", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stroke Volume", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA", 
          "id": "http://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jain", 
        "givenName": "Amit K.", 
        "id": "sg:person.01357346364.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357346364.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Division of Cardiovascular Diseases, Mayo Clinic and Foundation, 200 First Street SW, 55905, Rochester, MN, USA", 
          "id": "http://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Division of Cardiovascular Diseases, Mayo Clinic and Foundation, 200 First Street SW, 55905, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Horng H.", 
        "id": "sg:person.01024326700.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024326700.50"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/clpt.2013.136", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019834567", 
          "https://doi.org/10.1038/clpt.2013.136"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/s0009-9236(97)90067-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047412212", 
          "https://doi.org/10.1016/s0009-9236(97)90067-9"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-06-26", 
    "datePublishedReg": "2014-06-26", 
    "description": "Nesiritide and dopamine have been recognized for some time as potential renal adjunct therapies in the management of patients with acute heart failure (AHF). Several studies have yielded conflicting evidence of the efficacy of both medications in enhancing the renal function of patients with AHF. The Renal Optimization Strategies Evaluation (ROSE) study was a multicenter double-blind placebo controlled trial designed to assess the potential renoprotective effects of low-dose nesiritide and dopamine in AHF patients with renal dysfunction. This article will focus on previous research, summary of results, and lessons learned from the ROSE-AHF trial as well as future directions for clinical research and applications.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11897-014-0208-6", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2540938", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2437014", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1033049", 
        "issn": [
          "1546-9530", 
          "1546-9549"
        ], 
        "name": "Current Heart Failure Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "11"
      }
    ], 
    "keywords": [
      "acute heart failure", 
      "multicenter double-blind placebo", 
      "ROSE-AHF trials", 
      "double-blind placebo", 
      "management of patients", 
      "potential renoprotective effects", 
      "AHF patients", 
      "ROSE-AHF", 
      "renal function", 
      "renoprotective effects", 
      "renal dysfunction", 
      "adjunct therapy", 
      "heart failure", 
      "clinical research", 
      "patients", 
      "trials", 
      "dopamine", 
      "placebo", 
      "medications", 
      "evaluation study", 
      "dysfunction", 
      "therapy", 
      "efficacy", 
      "study", 
      "future directions", 
      "failure", 
      "evidence", 
      "management", 
      "summary", 
      "summary of results", 
      "effect", 
      "previous research", 
      "function", 
      "research", 
      "time", 
      "lessons", 
      "results", 
      "article", 
      "direction", 
      "applications", 
      "potential renal adjunct therapies", 
      "renal adjunct therapies", 
      "Renal Optimization Strategies Evaluation (ROSE) study", 
      "Optimization Strategies Evaluation (ROSE) study", 
      "Strategies Evaluation (ROSE) study"
    ], 
    "name": "ROSE-AHF and Lessons Learned", 
    "pagination": "260-265", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1043129398"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11897-014-0208-6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24966060"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11897-014-0208-6", 
      "https://app.dimensions.ai/details/publication/pub.1043129398"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_623.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11897-014-0208-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11897-014-0208-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11897-014-0208-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11897-014-0208-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11897-014-0208-6'


 

This table displays all metadata directly associated to this object as RDF triples.

168 TRIPLES      22 PREDICATES      82 URIs      71 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11897-014-0208-6 schema:about N358d57ef5b6a49a1878a6b62d9461473
2 N3f1f17ab3b9543fb9358b57dd9e621db
3 N4e169ba8fdaa405fb8358ae9ff869efd
4 N4fe8ab54981148ffbf5873c10513c323
5 Na47a41921ba34c2c89d5d650dd4afe10
6 Nb75cbf57ed0b44c2ae39331b5e67fe0f
7 Nbebe838552a94daaa6d95778f7fbf1f0
8 Nc7005b91fb864a85a87af16e75246613
9 Nef6a17e3c31a46c682fdd909931bbca3
10 anzsrc-for:11
11 anzsrc-for:1102
12 anzsrc-for:1103
13 schema:author N05531535b86d4502a4193f322f6e7144
14 schema:citation sg:pub.10.1016/s0009-9236(97)90067-9
15 sg:pub.10.1038/clpt.2013.136
16 schema:datePublished 2014-06-26
17 schema:datePublishedReg 2014-06-26
18 schema:description Nesiritide and dopamine have been recognized for some time as potential renal adjunct therapies in the management of patients with acute heart failure (AHF). Several studies have yielded conflicting evidence of the efficacy of both medications in enhancing the renal function of patients with AHF. The Renal Optimization Strategies Evaluation (ROSE) study was a multicenter double-blind placebo controlled trial designed to assess the potential renoprotective effects of low-dose nesiritide and dopamine in AHF patients with renal dysfunction. This article will focus on previous research, summary of results, and lessons learned from the ROSE-AHF trial as well as future directions for clinical research and applications.
19 schema:genre article
20 schema:inLanguage en
21 schema:isAccessibleForFree true
22 schema:isPartOf N307d84bce00a4cd69756cc886fa3c35f
23 Ndef8a0ecf55f49cf89233f87d3b52c09
24 sg:journal.1033049
25 schema:keywords AHF patients
26 Optimization Strategies Evaluation (ROSE) study
27 ROSE-AHF
28 ROSE-AHF trials
29 Renal Optimization Strategies Evaluation (ROSE) study
30 Strategies Evaluation (ROSE) study
31 acute heart failure
32 adjunct therapy
33 applications
34 article
35 clinical research
36 direction
37 dopamine
38 double-blind placebo
39 dysfunction
40 effect
41 efficacy
42 evaluation study
43 evidence
44 failure
45 function
46 future directions
47 heart failure
48 lessons
49 management
50 management of patients
51 medications
52 multicenter double-blind placebo
53 patients
54 placebo
55 potential renal adjunct therapies
56 potential renoprotective effects
57 previous research
58 renal adjunct therapies
59 renal dysfunction
60 renal function
61 renoprotective effects
62 research
63 results
64 study
65 summary
66 summary of results
67 therapy
68 time
69 trials
70 schema:name ROSE-AHF and Lessons Learned
71 schema:pagination 260-265
72 schema:productId Na397d4d883274b54a8ba33312667251a
73 Nb4441f4515314c94877df19c4d173c3f
74 Nd1f963bc72c4454fa223525b6b6a5dab
75 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043129398
76 https://doi.org/10.1007/s11897-014-0208-6
77 schema:sdDatePublished 2022-01-01T18:32
78 schema:sdLicense https://scigraph.springernature.com/explorer/license/
79 schema:sdPublisher Na0bb1225367940a7a32e1fc47ded6ae3
80 schema:url https://doi.org/10.1007/s11897-014-0208-6
81 sgo:license sg:explorer/license/
82 sgo:sdDataset articles
83 rdf:type schema:ScholarlyArticle
84 N05531535b86d4502a4193f322f6e7144 rdf:first sg:person.01357346364.14
85 rdf:rest N245839a936bc49c49776344599cc1f9c
86 N245839a936bc49c49776344599cc1f9c rdf:first sg:person.01024326700.50
87 rdf:rest rdf:nil
88 N307d84bce00a4cd69756cc886fa3c35f schema:volumeNumber 11
89 rdf:type schema:PublicationVolume
90 N358d57ef5b6a49a1878a6b62d9461473 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Dose-Response Relationship, Drug
92 rdf:type schema:DefinedTerm
93 N3f1f17ab3b9543fb9358b57dd9e621db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Acute Kidney Injury
95 rdf:type schema:DefinedTerm
96 N4e169ba8fdaa405fb8358ae9ff869efd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Stroke Volume
98 rdf:type schema:DefinedTerm
99 N4fe8ab54981148ffbf5873c10513c323 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Disease Progression
101 rdf:type schema:DefinedTerm
102 Na0bb1225367940a7a32e1fc47ded6ae3 schema:name Springer Nature - SN SciGraph project
103 rdf:type schema:Organization
104 Na397d4d883274b54a8ba33312667251a schema:name pubmed_id
105 schema:value 24966060
106 rdf:type schema:PropertyValue
107 Na47a41921ba34c2c89d5d650dd4afe10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Natriuretic Peptide, Brain
109 rdf:type schema:DefinedTerm
110 Nb4441f4515314c94877df19c4d173c3f schema:name dimensions_id
111 schema:value pub.1043129398
112 rdf:type schema:PropertyValue
113 Nb75cbf57ed0b44c2ae39331b5e67fe0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Heart Failure
115 rdf:type schema:DefinedTerm
116 Nbebe838552a94daaa6d95778f7fbf1f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Humans
118 rdf:type schema:DefinedTerm
119 Nc7005b91fb864a85a87af16e75246613 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Natriuretic Agents
121 rdf:type schema:DefinedTerm
122 Nd1f963bc72c4454fa223525b6b6a5dab schema:name doi
123 schema:value 10.1007/s11897-014-0208-6
124 rdf:type schema:PropertyValue
125 Ndef8a0ecf55f49cf89233f87d3b52c09 schema:issueNumber 3
126 rdf:type schema:PublicationIssue
127 Nef6a17e3c31a46c682fdd909931bbca3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Treatment Outcome
129 rdf:type schema:DefinedTerm
130 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
131 schema:name Medical and Health Sciences
132 rdf:type schema:DefinedTerm
133 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
134 schema:name Cardiorespiratory Medicine and Haematology
135 rdf:type schema:DefinedTerm
136 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
137 schema:name Clinical Sciences
138 rdf:type schema:DefinedTerm
139 sg:grant.2437014 http://pending.schema.org/fundedItem sg:pub.10.1007/s11897-014-0208-6
140 rdf:type schema:MonetaryGrant
141 sg:grant.2540938 http://pending.schema.org/fundedItem sg:pub.10.1007/s11897-014-0208-6
142 rdf:type schema:MonetaryGrant
143 sg:journal.1033049 schema:issn 1546-9530
144 1546-9549
145 schema:name Current Heart Failure Reports
146 schema:publisher Springer Nature
147 rdf:type schema:Periodical
148 sg:person.01024326700.50 schema:affiliation grid-institutes:grid.66875.3a
149 schema:familyName Chen
150 schema:givenName Horng H.
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024326700.50
152 rdf:type schema:Person
153 sg:person.01357346364.14 schema:affiliation grid-institutes:grid.66875.3a
154 schema:familyName Jain
155 schema:givenName Amit K.
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01357346364.14
157 rdf:type schema:Person
158 sg:pub.10.1016/s0009-9236(97)90067-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047412212
159 https://doi.org/10.1016/s0009-9236(97)90067-9
160 rdf:type schema:CreativeWork
161 sg:pub.10.1038/clpt.2013.136 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019834567
162 https://doi.org/10.1038/clpt.2013.136
163 rdf:type schema:CreativeWork
164 grid-institutes:grid.66875.3a schema:alternateName Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA
165 Division of Cardiovascular Diseases, Mayo Clinic and Foundation, 200 First Street SW, 55905, Rochester, MN, USA
166 schema:name Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA
167 Division of Cardiovascular Diseases, Mayo Clinic and Foundation, 200 First Street SW, 55905, Rochester, MN, USA
168 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...